Nocturnal asthma therapeutic considerations

Clinical Immunotherapeutics

Volumn 6, Issue 6, 1996, Pages 443-453

  Martin, Richard ^a   Kraft, Monica ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; OXITROPIUM BROMIDE; PREDNISONE; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE; TRIAMCINOLONE;

ASTHMA; CHRONOPHARMACOLOGY; CIRCADIAN RHYTHM; GASTROESOPHAGEAL REFLUX; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; RHINITIS; SINUSITIS;

EID: 0029768544     PISSN: 11727039     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03259366     Document Type: Article

References (60)

1. Turner-Warwick M, Epidemiology of nocturnal asthma. Am J Med 1988;86Suppl. IB: 6-8
2. Robertson CE, Rubinfeld AR, Bowej G, Deaths from asthma in Victoria: a 12-month study. MedJ Aust 1990; 152: 511-7
3. Dethlefsen U, Repgas R, Ein neues therapieprinzip bei nachtlichen asthma. Klin Med 1985; 80: 44-7
4. Heztel MR, Clark TJH, Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 1980; 35: 732-8
5. Martin RJ, Cicutto LC, Ballard RD, Factors related to the nocturnal worsening of asthma. Am Rev Respir Dis 1990; 141: 33-8
6. Martin RJ, Cicutto LC, Ballard RD, et al, Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991; 143: 351-7
7. Jarjour NN, Busse WW, Calhoun WJ, Enhanced production of oxygen radicals in nocturnal asthma. Am Rev Respir Dis 1992; 146:905-11
8. Barnes P, FitzGerald G, Brown M, et al, Nocturnal asthma and changes in circulatory epinephrine, histamine andcortisol. N EnglJMed 1980; 303: 263-7
9. Morrison JFJ, Pearson SB, Dean HG, Parasympathetic nervous system in nocturnal asthma. BMJ 1988; 296: 1427-9
10. Szefler SJ, Ando R, Cicutto LC, et al, Plasma histamine, epinephrine, cortisol, and leukocyte -adrenergic receptors in nocturnal asthma. Clin Pharmacol Ther 1991; 49: 59
11. Turki J, Pak J, Sa G, et al, Genetic polymorphisms of the -2 adrenergic receptor in nocturnal and nonnocturnal asthma. J Clin Invest 1995; 95: 1635
12. Chan CS, Woolcock AJ, Sullivan CE, Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis 1988; 137: 1502-4
13. Martin RJ, Pak J, Nasal CPAP in non-apneic nocturnal asthma. Chest 1991; 100: 1024-7
14. Moore JG, Wolfe M, The relation of plasma gastrin to the circadian rhythm of gastric acid secretion in man. Digestion 1073; 9: 97-105
15. Tan WC, Martin RJ, Pandey R, et al, Effects of spontaneous and simulated gastroesophageal reflux on sleeping asthmatics. Am Rev Respir Dis 1990; 141: 1394-9
16. Weiner P, Azgad Y, Ganum R, Specific inspiratory muscle training in patients with bronchial asthma. Chest 1992; 102: 1357-61
17. Chen WY, Horton DJ, Weiser PC, Airway obstruction induced by body cooling in asthmatics. Physiology 1977; 20: 16
18. Chen WY, Horton DJ, Airways obstruction in asthmatics induced by body cooling. Scand J Respir Dis 1978; 59: 13-20
19. Petersdorf RA, Disturbance of heat regulation. In: Wintrobe MM, Thorn GW, Actams RD, et al, editors. Harrison's principles of internal medicine. 7th ed. New York: McGraw-Hill, 1974
20. Chen WY, Chai H, Airway cooling and nocturnal asthma. Chest 1982:81:675-80
21. Shturman-Ellstein R, Zeballos RJ, Buckley JM, et al, The beneficial effect of nasal breathing on exercise-induced bronchoconstriction. Am Rev Respir Dis 1978; 118: 65-73
22. Brugman SM, Larsen GL, Henson PM, et al, Increased lower airways responsiveness associated with sinusitis in a rabbit model. Am Rev Respir Dis 1993; 147: 314-20
23. Postma DS, KoeterGH, Meurs H, et al, Slow release terbutaline in nocturnal bronchial obstruction: relation of terbutaline dosage and blood levels with circadian changes in peak flow values. Annu Rev Chronopharmacol 1984; 1: 101-4
24. Köeter GH, Postma DS, Keyzer JJ, et al, Effect of oral slow release terbutaline on early morning dyspnea. Eur J Clin Pharmacol 1995; 28: 159-62
25. Moore-Gillon J, Volmax (salbuterol CR 8mg) in the management of nocturnal asthma: a placebo-controlled study [abstract]. Eur Respir J 1988; 1 Suppl. 2: 306S
26. Storms WW, Nathan RA, Bodman SF, et al, The effect of repeat action albuterol sulfate (Proventii 'Repetabs') in nocturnal symptoms of asthma. J Asthma 1992; 29: 206-12
27. Ullman A, Svedmyr N. Salmeterol. a new long-acting inhaled betai-adrenoreceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 1988; 43: 674-8
28. Fitzpatrick MF, Mackay T, Driver H, et al, Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled 2 agonist. BMJ 1990; 301: 1365-8
29. Dahl R, Earnshaw JS, Palmer JBD, Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease. Eur Respir J 1991; 4: 1178-84
30. Smolensky MH, Scott PH, Kramer WG, Clinical significance of day-night differences in serum theophylline concentration with special reference to Theo-Dur. J Allergy Clin Immunol 1986; 78:716-22
31. Scott PH, Tabachnik E, MacLeod S, et al, Sustained-release theophylline for childhood asthma: evidence for circadian variation of theophylline pharmacokinetics. J Pediatr 1981; 99: 476-9
32. D'Alonzo GE, Smolensky MH, Feldman S, et al, Twenty-four hour lung function in adult patients with asthma. Am Rev Respir Dis 1990; 142: 84-90
33. Darrow P, Steinijans VW, Therapeutic advantage of unequal dosing of theophylline in patients with nocturnal asthma. Chronobiol Int 1987; 4: 349-57
34. Bruguerolle B, Philip-Joet R, Parrel M, et al, Unequal twicedaily, sustained-release theophylline dosing in chronic obstructive pulmonary disease. Chronobiol Int 1987; 4: 381-6
35. Schultz H-U, Frercks H-J, Hypa F, Vergleichende theophyllinserum-speigel messungen über 24 stunden nach knoventioneller dosierung eines theophyllin-retard-praparation über 4 tage. Therapiewoche 1984; 34: 536-43
36. Rhind GB, Connaughton JJ, McFie J, et al, Sustained release choline theophyllinate in nocturnal asthma. BMJ 1985; 291: 1605-7
37. Martin RJ, Cicutto LC, Ballard RD, et al, Circadian variations in theophylline concentrations and the treatment of nocturnal asthma. Am Rev Respir Dis 1989; 139: 475-8
38. Welsh PW, Reed CE, Conrad E, Timing of one-a-day theophylline dose to match peak blood level with diurnal variation in severity of asthma. Am J Med 1986; 80: 1098-102
39. Goldenheim PD, Conrad EA, Schein LK. Treatment of asthma hy a controlled-reJease theophylline tablet formulation: a review of the North American experience with nocturnal dosing. Chronobiol Int 1987; 4: 387-408
40. Arkinstall WW, Review of the North American experience with evening administration of Uniphyl tablets, a once-daily theophylline preparation, in the treatment of nocturnal asthma. Am J Med 1988: 85 Suppl. IB: 60-3
41. Rivington RD, Calcutt L, Child S, étal, Comparison of morning versus evening dosing with a new once-daily oral theophylline formulation. Am J Med 1985; 79 Suppl. 6A: 67-72
42. Busse WW, Busch RK, Comparison of morning and evening dosing with a 24-hour sustained-release theophylline, Uniphyl, for nocturnal asthma. Am J Med 1985; 79 Suppl. 6A: 62-9
43. Arkinstall WW, Atkins ME. Harrison D, et al. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomology in adult asthmatics. Am Rev RespirDis 1987: 135:475-8
44. Reinberg A, Chronopharmacology: cellular and biochemical interactions. In: Lemmer B, editor. Chronopharmacology of corticosteroids and ACTH. New York: Marcel-Dekker. I989: 137-67
45. Reinberg AE, Orcadian timing of methylprednisolone effects in asthmatic boys. Chronobiologia 1974; I: 333-47
46. Reinberg A, Gervais P, Chaussade M, et al. Orcadian changes in effectiveness of corticosteroids in eight patients with allergic asthma. J Allergy Clin Immunol 1983:71:425-33
47. Reinberg A, Guillet P, Gervais P, et al, One month chronocorticotherapy: control of the asthmatic condition without adrenal suppression and circadian rhythm alterations. Chronobiologia 1977; 4: 295-312
48. Beam WR, Weiner DE, Martin RJ, Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am Rev RespirDis 1992; 146: 1524-30
49. Malo JL, Cortier A, Merland N, et al, Four times a day dosing frequency is better than twice a day regimen in subjects requiring a high dose inhaled steroid, budesonide, to control moderate to severe asthma. Am Rev Respir Dis 1989; 140: 6214-8
50. Horn CB, Clark TJH. Cochrane GM. Inhaler therapy reduces morning dips in asthma. Lancet 1984; I: 1143-5
51. Toogood JH, Baskerville JC, Jennings B. et al. Influence of dosing frequency and schedule on the response of chronic asthmatics to aerosol steroid, hudesonide. J Allergy Clin Iminunol 1982; 70: 288-98
52. Pincus DJ, Szefler SJ, Ackerson LM, et al. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1995; 95: 1172-8
53. Berntstein IL, Siegel SC, Brandon ML. et al. A controlled study of cromolyn sodium sponsored by the Drug Committee of the American Academy of Allergy. J Allergy Clin Immunol 1972; 50: 235-345
54. Hetzel MR, Clarke JH, Gilliam SJ, et al, Is sodium cromoglycate effective in nocturnal asthma? Thorax 1985; 40: 793-4
55. Morgan AD, Connaughton JJ, Caterall JR. et al. Sodium cromoglycate in nocturnal asthma. Thorax 1986; 41: 39-41
56. Ruffin R, Alpers JH, Kromer DK, et al, A 4-week Australian multicentre study of nedocromil sodium in asthmatic patients. Eur J Respir Dis 1986; 69 Suppl. 147: 336-9
57. Williams AJ, Stahleforth D, The addition of nedocromil sodium to maintenance therapy in the management of patients with bronchial asthma. Eur J Respir Dis 1986; 69 Suppl. 147: 340-3
58. CoeCI, Barnes PJ, Reduction of nocturnal asthma by an inhaled anticholinergic drug. Chest 1986; 90: 486-8
59. Fisher LE, Ludwig EA, Wald JA, et al. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 AM versus 4 PM. Clin Pharmacol Ther 1992: 51: 677-88
60. Correspondence and reprints: Dr Richard }, Martin, National Jewish Center for Immunology and Respiratory Medicine, 1400 Jackson Street, J116, Denver, CO 80206, USA.